Youth at entry to residential treatment: Understanding psychotropic medication use

Salvato in:

Dettagli Bibliografici
Autore principale:	Griffith, A.K
Altri autori:	ET AL
Natura:	Libro
Lingua:	spagnolo inglese
Soggetti:	Consumo Enfermedades mentales Fármacos Juventud Menores Predicción Servicios psiquiátricos Tratamiento médico EE.UU. Documental
Accesso online:	DOI Path
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi: Youth at entry to residential treatment: Understanding psychotropic medication use

Anteprima rapida
Foster youth and psychotropic treatment: Where next?
Anteprima rapida
Prevalence, patterns and factors associated with psychotropic use in older adults with intellectual disabilities in Ireland
Anteprima rapida
RECEIPT OF PSYCHOTROPIC MEDICATION BY PEOPLE WITH INTELLECTUAL DISABILITY IN RESIDENTIAL SETTINGS
Anteprima rapida
COMPLIANCE WITH PSYCHOTROPIC MEDICATION TREATMENT AMONG ADOLESCENTS LIVING IN YOUTH CARE CENTRES
Anteprima rapida
PSYCHOTROPIC MEDICATION MANAGEMENT IN PERSONS WITH CO-OCCURRING PSYCHIATRIC AND SUBSTANCE USE DISORDERS
Anteprima rapida
PROFESSIONALS' PERCEPTIONS OF PSYCHOTROPIC MEDICATION IN RESIDENTIAL FACILITIES FOR INDIVIDUALS WITH MENTAL RETARDATION
Anteprima rapida
MENTAL ILLNESS AND PSYCHOTROPIC MEDICATION USE IN THE NURSING HOME
Anteprima rapida
PSYCHOTROPIC MEDICATION FOR ADHD
Anteprima rapida
ASSOCIATION BETWEEN IMPROVEMENT IN DEPRESSION, REDUCED BENZODIAZEPINE (BDZ) ABUSE, AND INCREASED PSYCHOTROPIC MEDICATION USE IN METHADONE MAINTENANCE TREATMENT (MMT) PATIENTS
Anteprima rapida
PSYCHOPHARMACOLOGICAL INTERVENTION. II: TEACHER PERCEPTIONS OF PSYCHOTROPIC MEDICATION FOR STUDENTS WITH LEARNING DISABILITIES
Anteprima rapida
AN EXAMINATION OF PSYCHOTROPIC MEDICATION SIDE EFFECTS: DOES TAKING A GREATER NUMBER OF PSYCHOTROPIC MEDICATIONS FROM DIFFERENT CLASSES AFFECT PRESENTATION OF SIDE EFFECTS IN ADULTS WITH ID?
Anteprima rapida
The effect of biannual medication reviews on the appropriateness of psychotropic drug use for neuropsychiatric symptoms in patients with dementia: a randomised controlled trial
Anteprima rapida
REVIEW OF STATES' PRACTICES ON THE USE OF PSYCHOTROPIC MEDICATION
Anteprima rapida
PSYCHOTROPIC MEDICATION USE FOR CHALLENGING BEHAVIORS IN PERSONS WITH INTELLECTUAL DISABILITIES: AN OVERVIEW
Anteprima rapida
PREVALENCE AND PREDICTION OF PSYCHOTROPIC DRUG USE IN CALIFORNIA DEVELOPMENTAL CENTERS
Anteprima rapida
THE USE OF PSYCHOTROPIC MEDICATION FOR THE MANAGEMENT OF PROBLEM BEHAVIOURS IN ADULTS WITH INTELLECTUAL DISABILITIES LIVING IN CANADA
Anteprima rapida
Factors predicting substance dependence and psychotropic medication use among offenders in community corrections
Anteprima rapida
THE MEANING OF PSYCHOTROPIC MEDICATIONS FOR CHILDREN, ADOLESCENTS, AND THEIR FAMILIES
Anteprima rapida
THE RELATIONSHIP BETWEEN NURSE CHARACTERISTICS AND PERCEPTIONS OF PSYCHOTROPIC MEDICATIONS IN RESIDENTIAL FACILITIES FOR THE RETARDED
Anteprima rapida
GUIDELINES FOR THE USE OF PSYCHOTROPIC MEDICATION IN INDIVIDUALS WITH DEVELOPMENTAL DISABILITIES
Anteprima rapida
Prader–Willi syndrome in a large sample from Spain: general features, obesity and regular use of psychotropic medication
Anteprima rapida
PRESCRIPTION OF PSYCHOTROPIC MEDICATION TO PEOPLE WITH INTELLECTUAL DISABILITIES IN PRIMARY HEALTH-CARE SETTINGS
Anteprima rapida
COCAINE WITHDRAWAL SEVERITY AND URINE TOXICOLOGY RESULTS FROM TREATMENT ENTRY PREDICT OUTCOME IN MEDICATION TRIALS FOR COCAINE DEPENDENCE
Anteprima rapida
A CONSUMER'S GUIDE TO MONITORING PSYCHOTROPIC MEDICATION FOR INDIVIDUALS WITH AUTISM SPECTRUM DISORDERS